Sommaire

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A4

    
• • ·Information for Readers

    Page :A5

    

• Editorials

  • ·The “rise of the rule out”: The SPECTer of cardiac stress imaging

    Page :122-124

    Elmer Philip Lehman, Pamela S. Douglas

    
  • ·Tackling cardiovascular disease in Hispanic/Latinos: Achieving 2020 Goals

    Page :125-126

    Hector O. Ventura, Carl J. Lavie

    

• Curriculum in Cardiology

  • ·Switching of platelet P2Y₁₂ receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Review of the literature and practical considerations

    Page :44-52

    Leonardo De Luca, Piera Capranzano, Giuseppe Patti, Guido Parodi

    Résumé Résumé Plan Plan  
  • ·The on- and off-target effects of morphine in acute coronary syndrome: A narrative review

    Page :114-121

    Cian P. McCarthy, Kieran V. Mullins, Sunjeet S. Sidhu, Steven P. Schulman, John W. McEvoy

    Résumé Résumé Plan Plan  

• Trial Designs

  • ·Rationale and design of the First Brazilian Cardiovascular Registry of Atrial Fibrillation: The RECALL study

    Page :10-16

    Renato D. Lopes, Angelo Amato Vicenzo de Paola, Adalberto Menezes Lorga Filho, Fernanda Marciano Consolim-Colombo, Jadelson Andrade, Luiz Alberto Piva e Mattos, Sabrina Bernardez-Pereira, Otávio Berwanger, Marcio Jansen de Oliveira Figueiredo, RECALL Steering Committee and Investigators

    Résumé Résumé Plan Plan   
  • ·Treatment of anxiety in patients with coronary heart disease: Rationale and design of the UNderstanding the benefits of exercise and escitalopram in anxious patients WIth coroNary heart Disease (UNWIND) randomized clinical trial

    Page :53-62

    James A. Blumenthal, Bryan J. Feger, Patrick J. Smith, Lana L. Watkins, Wei Jiang, Jonathan Davidson, Benson M. Hoffman, Megan Ashworth, Stephanie K. Mabe, Michael A. Babyak, William E. Kraus, Alan Hinderliter, Andrew Sherwood

    Résumé Résumé Plan Plan   
  • ·Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound (GLAGOV)

    Page :83-92

    Rishi Puri, Steven E. Nissen, Ransi Somaratne, Leslie Cho, John J.P. Kastelein, Christie M. Ballantyne, Wolfgang Koenig, Todd J. Anderson, Jingyuan Yang, Helina Kassahun, Scott M. Wasserman, Robert Scott, Marilyn Borgman, Stephen J. Nicholls

    Résumé Résumé Plan Plan  
  • ·A clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AF): design and rationale

    Page :107-113

    Meena P. Rao, Andrea O. Ciobanu, Renato D. Lopes, Kathleen A. Fox, Ying Xian, Sean D. Pokorney, Hussein R. Al-Khalidi, Jei Jiang, Deepak Y. Kamath, Otavio Berwanger, Denis Xavier, Cecilia M. Bahit, Carlos Tajer, Dragos Vinereanu, Yong Huo, Christopher B. Granger

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·Percutaneous coronary intervention for older adults who present with syncope and coronary artery disease? Insights from the National Cardiovascular Data Registry

    Page :1-9

    Lindsay L. Anderson, David Dai, Amy Leigh Miller, Matthew T. Roe, John C. Messenger, Tracy Y. Wang

    Résumé Résumé Plan Plan  
  • ·Impact of an Atrial Fibrillation Decision Support Tool on thromboprophylaxis for atrial fibrillation

    Page :17-27

    Mark H. Eckman, Gregory Y.H. Lip, Ruth E. Wise, Barbara Speer, Megan Sullivan, Nita Walker, Brett Kissela, Matthew L. Flaherty, Dawn Kleindorfer, Peter Baker, Robert Ireton, Dave Hoskins, Brett M. Harnett, Carlos Aguilar, Anthony C. Leonard, Lora Arduser, Dylan Steen, Alexandru Costea, John Kues

    Résumé Résumé Plan Plan   
  • ·Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial

    Page :28-35

    Liefke C. van der Heijden, Marlies M. Kok, Peter W. Danse, Alexander R. Schramm, Marc Hartmann, Marije M. Löwik, Gerard C.M. Linssen, Martin G. Stoel, Carine J.M. Doggen, Clemens von Birgelen

    Résumé Résumé Plan Plan  
  • ·Extended duration dual antiplatelet therapy in patients with myocardial infarction: A study-level meta-analysis of controlled randomized trials

    Page :36-43

    Giuseppe Patti, Ilaria Cavallari

    Résumé Résumé Plan Plan  
  • ·Protocol for analyses of adverse event data from randomized controlled trials of statin therapy

    Page :63-69

    Cholesterol Treatment Trialists' (CTT) Collaboration ? C.ReithL.BlackwellJ.EmbersonB.MihaylovaJ.ArmitageJ.FulcherA.KeechJ.SimesC.BaigentR.Collins, C. Reith, L. Blackwell, J. Emberson, B. Mihaylova, J. Armitage, J. Fulcher, A. Keech, J. Simes, C. Baigent, R. Collins

    Résumé Résumé Plan Plan
  • ·Racial and ethnic differences in atrial fibrillation risk factors and predictors in women: Findings from the Women's Health Initiative

    Page :70-77

    Fatima Rodriguez, Marcia L. Stefanick, Philip Greenland, Elsayed Z. Soliman, JoAnn E. Manson, Nisha Parikh, Lisa W. Martin, Joseph C. Larson, Mark Hlatky, Rami Nassir, Crystal W. Cené, Beatriz L. Rodriguez, Christine Albert, Marco V. Perez

    Résumé Résumé Plan Plan  
  • ·Low real-world early stent thrombosis rates in ST-elevation myocardial infarction patients and the use of bivalirudin, heparin alone or glycoprotein IIb/IIIa inhibitor treatment: A nationwide Swedish registry report

    Page :78-82

    Per Grimfjärd, David Erlinge, Sasha Koul, Bo Lagerqvist, Bodil Svennblad, Christoph Varenhorst, Stefan James

    Résumé Résumé Plan Plan  
  • ·Shock complicating type A acute aortic dissection: Clinical correlates, management, and outcomes

    Page :93-99

    Eduardo Bossone, Reed E. Pyeritz, Alan C. Braverman, Mark D. Peterson, Marek Ehrlich, Patrick O'Gara, Toru Suzuki, Santi Trimarchi, Dan Gilon, Kevin Greason, Nimesh D. Desai, Daniel G. Montgomery, Eric M. Isselbacher, Christoph A. Nienaber, Kim A. Eagle, IRAD Investigators

    Résumé Résumé Plan Plan  
  • ·Asymmetric dimethylarginine, related arginine derivatives, and incident atrial fibrillation

    Page :100-106

    Renate B. Schnabel, Renke Maas, Na Wang, Xiaoyan Yin, Martin G. Larson, Daniel Levy, Patrick T. Ellinor, Steven A. Lubitz, David D. McManus, Jared W. Magnani, Dorothee Atzler, Rainer H. Böger, Edzard Schwedhelm, Ramachandran S. Vasan, Emelia J. Benjamin

    Résumé Résumé Plan Plan   
  • ·Temporal trends of single-photon emission computed tomography myocardial perfusion imaging in patients without prior coronary artery disease: A 22-year experience at a tertiary academic medical center

    Page :127-133

    Hayan Jouni, J. Wells Askew, Daniel J. Crusan, Todd D. Miller, Raymond J. Gibbons

    Résumé Résumé Plan Plan  
  • ·Cardiovascular health among diverse Hispanics/Latinos: Hispanic Community Health Study/Study of Latinos (HCHS/SOL) results

    Page :134-144

    Hector M. González, Wassim Tarraf, Carlos J. Rodríguez, Linda C. Gallo, Ralph L. Sacco, Gregory A. Talavera, Gerardo Heiss, Jorge R. Kizer, Rosalba Hernandez, Sonia Davis, Neil Schneiderman, Martha L. Daviglus, Robert C. Kaplan

    Résumé Résumé Plan Plan   

• Letter to the Editors

  • ·Higher mortality among males in takotsubo cardiomyopathy

    Page :e1

    Sadip Pant, Abhishek Deshmukh

    
  • ·Response to “Higher mortality among males in takotsubo cardiomyopathy”

    Page :e3

    Rohan Khera, Saket Girotra

    
  • ·The nonsense paradigm of rethinking the second link of the chain of survival: “if shock is not advised, wait and do nothing!” Aren’t we condemning our cardiac arrest patients?

    Page :e5

    Giuseppe Ristagno, Tommaso Pellis, Federico Semeraro, Italian Resuscitation Council

    
  • ·Rebuttal of critique of Progetto Vita survival data

    Page :e7

    Alessandro Capucci, Daniela Aschieri, Federico Guerra, Valentina Pelizzoni, Gust H. Bardy